COMBINATION OF A PD-1 ANTAGONIST, AN ATR INHIBITOR AND A PLATINATING AGENT FOR THE TREATMENT OF CANCER

The present invention relates to combination therapies useful for the treatment of cancer. In particular, the invention relates to a therapeutic combination which comprises a PD-1 antagonist, an ATR inhibitor and a platinating agent. 本发明涉及用于治疗癌症的组合疗法。特别地,本发明涉及包含PD-1拮抗剂、ATR抑制剂和铂化物质的治疗组合。...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: SCHRODER ALOYS, ZIMMERMANN ADRIAN, DAHMEN HEIKE, TADJALLI MEHR KEYVAN, ALIMZHANOV MARAT, SOULARD PATRICIA, ZENKE FRANK, FALK MAX
Format: Patent
Sprache:chi ; eng
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:The present invention relates to combination therapies useful for the treatment of cancer. In particular, the invention relates to a therapeutic combination which comprises a PD-1 antagonist, an ATR inhibitor and a platinating agent. 本发明涉及用于治疗癌症的组合疗法。特别地,本发明涉及包含PD-1拮抗剂、ATR抑制剂和铂化物质的治疗组合。